Your institution may have access to this item. Find your institution then sign in to continue.
Title
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.
Authors
Goldhaber-Fiebert, Jeremy D; Stout, Natasha K; Salomon, Joshua A; Kuntz, Karen M; Goldie, Sue J
Abstract
The availability of human papillomavirus (HPV) DNA testing and vaccination against HPV types 16 and 18 (HPV-16,18) motivates questions about the cost-effectiveness of cervical cancer prevention in the United States for unvaccinated older women and for girls eligible for vaccination.
Publication
Journal of the National Cancer Institute, 2008, Vol 100, Issue 5, p308